Monitor for additional insider selling in the coming weeks; isolated small-volume sales by executives are common and typically not predictive, but sustained selling could signal concern.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 17 $47.28entry
- T+1 · 8mo ago −5.96%α −4.57% · $44.46
- T+5 · 8mo ago +0.44%α +3.10% · $47.49
- T+20 · 7mo ago +21.87%α +17.57% · $57.62
- T+60 · 5mo ago +48.18%α +38.32% · $70.06
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three insiders at Twist Bioscience sold shares in a coordinated open-market transaction on March 20, 2026, including CEO Emily Leproust. The total value of the sales was approximately $104,800, representing a small fraction of the company's $2.7B market cap.
Key Financial Metrics
Key Facts
- CEO Emily Leproust sold 1,742 shares worth $76,276 in an open-market transaction.
- Dennis Cho and SVP Paula Green sold 354 and 297 shares, respectively, on the same day and price.
- All transactions were open-market sales (code S) and occurred at $43.7864 per share.
- Total value of the cluster: $104,781, representing ~0.0039% of the company's $2.7B market cap.
Financial Impact
$104,781 in total insider sales
Risk Factors
- Perception of insider lack of confidence if selling continues ahead of earnings or key events.
- Potential misinterpretation of routine portfolio management as negative sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-TWST-1774382743238 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers